These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 32626960)
41. Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA. Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C Biomed Res Int; 2018; 2018():4246703. PubMed ID: 30356407 [TBL] [Abstract][Full Text] [Related]
42. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis. Hou J; Yao C Biomed Res Int; 2021; 2021():8859996. PubMed ID: 33511215 [TBL] [Abstract][Full Text] [Related]
43. Analyzing the lncRNA, miRNA, and mRNA-associated ceRNA networks to reveal potential prognostic biomarkers for glioblastoma multiforme. Zhu X; Jiang L; Yang H; Chen T; Wu X; Lv K Cancer Cell Int; 2020; 20():393. PubMed ID: 32821246 [TBL] [Abstract][Full Text] [Related]
44. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma. Dong C; Fan W; Fang S J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063 [TBL] [Abstract][Full Text] [Related]
45. Long noncoding RNAs predict the survival of patients with colorectal cancer as revealed by constructing an endogenous RNA network using bioinformation analysis. Zhang H; Wang Z; Wu J; Ma R; Feng J Cancer Med; 2019 Mar; 8(3):863-873. PubMed ID: 30714675 [TBL] [Abstract][Full Text] [Related]
46. Integrated Gene Expression Data-Driven Identification of Molecular Signatures, Prognostic Biomarkers, and Drug Targets for Glioblastoma. Alom MW; Jibon MDK; Faruqe MO; Rahman MS; Akter F; Ali A; Rahman MM Biomed Res Int; 2024; 2024():6810200. PubMed ID: 39184354 [TBL] [Abstract][Full Text] [Related]
47. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network. Tang Z; Wei G; Zhang L; Xu Z Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106 [TBL] [Abstract][Full Text] [Related]
48. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236 [TBL] [Abstract][Full Text] [Related]
49. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression. Bai Y; Long J; Liu Z; Lin J; Huang H; Wang D; Yang X; Miao F; Mao Y; Sang X; Zhao H J Cell Physiol; 2019 Aug; 234(10):18837-18848. PubMed ID: 30916406 [TBL] [Abstract][Full Text] [Related]
50. Identification of biomarkers and ceRNA network in glioblastoma through bioinformatic analysis and evaluation of potential prognostic values. Hong F; Gong Z; Zhang X; Ma P; Yin Y; Wang H Ann Transl Med; 2021 Oct; 9(20):1561. PubMed ID: 34790767 [TBL] [Abstract][Full Text] [Related]
51. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma. Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886 [TBL] [Abstract][Full Text] [Related]
52. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249 [TBL] [Abstract][Full Text] [Related]
53. Identifying Molecular Markers of Cervical Cancer Based on Competing Endogenous RNA Network Analysis. Qin S; Gao Y; Yang Y; Zhang L; Zhang T; Yu J; Shi C Gynecol Obstet Invest; 2019; 84(4):350-359. PubMed ID: 30625468 [TBL] [Abstract][Full Text] [Related]
54. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma. Zhou D; Gao B; Yang Q; Kong Y; Wang W Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187 [TBL] [Abstract][Full Text] [Related]
55. SLC12A5 as a novel potential biomarker of glioblastoma multiforme. Chen J; Wang H; Deng C; Fei M Mol Biol Rep; 2023 May; 50(5):4285-4299. PubMed ID: 36917367 [TBL] [Abstract][Full Text] [Related]
56. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs). Xu Y; Chen J; Yang Z; Xu L Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559 [TBL] [Abstract][Full Text] [Related]
57. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data. Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068 [TBL] [Abstract][Full Text] [Related]
58. LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastoma multiforme. Yan Y; Zhang L; Jiang Y; Xu T; Mei Q; Wang H; Qin R; Zou Y; Hu G; Chen J; Lu Y J Cancer Res Clin Oncol; 2015 May; 141(5):827-38. PubMed ID: 25378224 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of secretome biomarkers in glioblastoma cancer stem cells: A bioinformatics analysis. Jangholi E; Tehran HA; Ghasemi A; Hoseinian M; Firoozi S; Ghodsi SM; Tamaddon M; Bereimipour A; Hadjighassem M Cancer Rep (Hoboken); 2024 Jul; 7(7):e2080. PubMed ID: 38967113 [TBL] [Abstract][Full Text] [Related]
60. Microarray expression profiles and bioinformatics analysis of mRNAs, lncRNAs, and circRNAs in the secondary temozolomide-resistant glioblastoma. Zhao C; Gao Y; Guo R; Li H; Yang B Invest New Drugs; 2020 Oct; 38(5):1227-1235. PubMed ID: 31823158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]